- Home
- HCM vs SEB Comparison
HCM vs SEB Comparison
Compare HCM & SEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- SEB
- Stock Information
- Founded
- HCM 2000
- SEB 1918
- Country
- HCM Hong Kong
- SEB United States
- Employees
- HCM N/A
- SEB N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- SEB Farming/Seeds/Milling
- Sector
- HCM Health Care
- SEB Industrials
- Exchange
- HCM Nasdaq
- SEB Nasdaq
- Market Cap
- HCM 2.3B
- SEB 2.4B
- IPO Year
- HCM N/A
- SEB N/A
- Fundamental
- Price
- HCM $13.52
- SEB $2,465.85
- Analyst Decision
- HCM Hold
- SEB
- Analyst Count
- HCM 1
- SEB 0
- Target Price
- HCM $19.00
- SEB N/A
- AVG Volume (30 Days)
- HCM 85.0K
- SEB 2.1K
- Earning Date
- HCM 02-26-2025
- SEB 02-11-2025
- Dividend Yield
- HCM N/A
- SEB 0.37%
- EPS Growth
- HCM N/A
- SEB N/A
- EPS
- HCM N/A
- SEB N/A
- Revenue
- HCM $610,806,000.00
- SEB $8,900,000,000.00
- Revenue This Year
- HCM N/A
- SEB N/A
- Revenue Next Year
- HCM $18.76
- SEB N/A
- P/E Ratio
- HCM N/A
- SEB N/A
- Revenue Growth
- HCM N/A
- SEB N/A
- 52 Week Low
- HCM $13.00
- SEB $2,365.00
- 52 Week High
- HCM $21.92
- SEB $3,614.95
- Technical
- Relative Strength Index (RSI)
- HCM 40.71
- SEB 48.14
- Support Level
- HCM $13.10
- SEB $2,436.45
- Resistance Level
- HCM $13.92
- SEB $2,505.00
- Average True Range (ATR)
- HCM 0.38
- SEB 55.52
- MACD
- HCM 0.02
- SEB 4.63
- Stochastic Oscillator
- HCM 37.96
- SEB 48.38
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About SEB Seaboard Corporation
Seaboard Corp is a diversified group of companies that operate in agricultural and ocean transport businesses. The company is engaged in hog production and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group operates six business segments: pork, commodity trading and milling, marine, sugar and alcohol, power, turkey and others. It operates in 45 countries, with a concentration in the U.S. and countries in Central and South America and Africa.